Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesenteric defect closure versus non-closure after complete mesocolic excision in minimally invasive right colectomy: a retrospective study.

International journal of colorectal disease·2026
Same author

The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes.

Science advances·2026
Same author

Safety outcomes in 602 GERD patients treated by RefluxStop: a multi-center real-world study from 22 centers across six European countries.

Scientific reports·2026
Same author

Cost-effectiveness of RefluxStop for gastroesophageal reflux disease: analysis from an Italian healthcare perspective.

BMC gastroenterology·2026
Same author

Designing a national network of pancreas units: the Italian model for high-quality pancreatic cancer care.

Updates in surgery·2026
Same author

Integrated single cell RNA sequencing and flow cytometry analysis identifies elevated S100A6<sup>+</sup> and S100A8<sup>+</sup> myeloid subsets in pancreatic ductal adenocarcinoma.

Clinical immunology (Orlando, Fla.)·2026

Related Experiment Video

Updated: Oct 3, 2025

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

404

Laparoscopic partial splenectomy for symptomatic benign cystic lesions: technical notes.

Salvatore Fedele1, Cinzia Bizzoca2, Fabrizio Aquilino3

  • 1General Surgery Unit, National Institute of Gastroenterology IRCCS Saverio de Bellis, Research Hospital, via Turi 27, Castellana Grotte, 70013, Bari, Italy. salvatorefedele.md@gmail.com.

Updates in Surgery
|February 12, 2022
PubMed
Summary

Laparoscopic partial splenectomy (LPS) is a feasible surgical option for benign spleen lesions, offering spleen preservation with minimal complications. This minimally invasive approach demonstrates successful outcomes and short recovery times.

Keywords:
LaparoscopicPartial splenectomySplenectomySplenic cystsSplenic resection

More Related Videos

Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
04:40

Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device

Published on: November 4, 2022

1.2K
Application of Microwave Ablation in Laparoscopic Partial Splenectomy
03:49

Application of Microwave Ablation in Laparoscopic Partial Splenectomy

Published on: November 15, 2024

288

Related Experiment Videos

Last Updated: Oct 3, 2025

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions
02:09

Application of Laparoscopic Partial Splenectomy with Total Blood Flow Occlusion in Benign Splenic Lesions

Published on: December 20, 2024

404
Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
04:40

Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device

Published on: November 4, 2022

1.2K
Application of Microwave Ablation in Laparoscopic Partial Splenectomy
03:49

Application of Microwave Ablation in Laparoscopic Partial Splenectomy

Published on: November 15, 2024

288

Area of Science:

  • Surgical Oncology
  • Minimally Invasive Surgery
  • Gastroenterology

Background:

  • Benign splenic lesions can cause symptoms requiring intervention.
  • Traditional surgical approaches may involve significant morbidity.
  • Spleen preservation is desirable to maintain immune function.

Purpose of the Study:

  • To evaluate the feasibility and short-term outcomes of laparoscopic partial splenectomy (LPS) for symptomatic benign splenic lesions.
  • To assess the safety and efficacy of LPS in a clinical setting.

Main Methods:

  • Retrospective analysis of 7 patients who underwent LPS for benign lesions between April 2017 and February 2020.
  • Evaluation of operative results, including operative time, blood loss, and complications.
  • Assessment of short-term outcomes and 6-month follow-up, including tumor markers and platelet counts.

Main Results:

  • LPS was successfully performed in all 7 cases without major complications or conversion to open surgery.
  • No 30-day mortality, post-operative transfusions, or need for total splenectomy.
  • Median hospital stay was 4 days, with a median operative time of 110 minutes and mean blood loss of 135.7 ml.
  • Successful recovery with significant decrease in Ca 19.9 and normal platelet counts at 1-month follow-up.
  • No recurrence detected during 6-month follow-up.

Conclusions:

  • Laparoscopic partial splenectomy is a challenging yet feasible procedure for benign splenic lesions.
  • The technique offers the benefits of minimally invasive surgery while preserving the spleen.
  • LPS is a safe and effective option for select patients with symptomatic benign spleen lesions.